Sangeeta Bhaskar

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial

Surendra K. Sharma, Kiran Katoch, Rohit Sarin et al. · Scientific Reports · 2017 · 109 citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model

Aniruddha Roy, Manu Smriti Singh, Pramod Upadhyay et al. · International Journal of Pharmaceutics · 2013 · 67 citations

Medicine, Immunology, Oncology +17

Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung

Ankan Gupta, Farhan Jalees Ahmad, Faiz Ahmad et al. · PLoS ONE · 2012 · 67 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

A simple method for efficient extraction and purification of C-phycocyanin from Spirulina platensis Geitler.

Sangeeta Bhaskar, G Gopalaswamy, Rajasekaran Raghu · PubMed · 2005 · 62 citations

Life Sciences, Biochemistry, Food Science +12

Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice

Faiz Ahmad, Jiju Mani, Pawan Kumar et al. · PLoS ONE · 2011 · 57 citations · Full text

Medicine, Immunology, Oncology +17